Correction to: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung Adenocarcinoma

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastasis ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Egfr Mutant

Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma

Targeted Oncology ◽

10.1007/s11523-019-00649-1 ◽

2019 ◽

Vol 14 (4) ◽

pp. 423-431

Author(s):

Changhui Li ◽

Bo Zhang ◽

Jindong Guo ◽

Fang Hu ◽

Wei Nie ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastasis ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Egfr Mutant

Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.07.032 ◽

2017 ◽

Vol 12 (12) ◽

pp. 1766-1778 ◽

Cited By ~ 15

Author(s):

Jia Zhong ◽

Lei Li ◽

Zhijie Wang ◽

Hua Bai ◽

Fei Gai ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Resistance Mechanisms ◽

Primary Resistance ◽

A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors

Cancer Research and Treatment ◽

10.4143/crt.2016.058 ◽

2017 ◽

Vol 49 (1) ◽

pp. 10-19 ◽

Cited By ~ 25

Author(s):

Ji-Youn Han ◽

Ki Hyeong Lee ◽

Sang-We Kim ◽

Young Joo Min ◽

Eunkyung Cho ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Phase Ii Study ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)

Annals of Palliative Medicine ◽

10.21037/apm-21-2828 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Jinfei Si ◽

Xiaodong Gu ◽

Wenxian Wang ◽

Shenpeng Ying ◽

Zhengbo Song

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Egfr Mutations ◽

Acquired resistance to epidermal growth factor receptor (EGFR) kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8056 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8056-8056

Author(s):

J. Bean ◽

G. J. Riely ◽

M. Balak ◽

J. L. Marks ◽

M. Ladanyi ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Egfr Mutant ◽

Egfr Kinase

Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations

Lung Cancer ◽

10.1016/j.lungcan.2014.01.022 ◽

2014 ◽

Vol 84 (2) ◽

pp. 196-202 ◽

Cited By ~ 33

Author(s):

Min Hwan Kim ◽

Hye Ryun Kim ◽

Byoung Chul Cho ◽

Mi Kyung Bae ◽

Eun Young Kim ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Cigarette Smoking ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Egfr Mutations ◽

Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-0151 ◽

2008 ◽

Vol 14 (22) ◽

pp. 7519-7525 ◽

Cited By ~ 175

Author(s):

James Bean ◽

Gregory J. Riely ◽

Marissa Balak ◽

Jenifer L. Marks ◽

Marc Ladanyi ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Receptor Kinase ◽

Epidermal Growth ◽

Egfr Mutant

MET overexpression coexisting with epidermal growth factor receptor mutation influence clinical efficacy of EGFR-tyrosine kinase inhibitors in lung adenocarcinoma patients

Translational Cancer Research ◽

10.21037/tcr.2017.03.49 ◽

2017 ◽

Vol 6 (2) ◽

pp. 409-415

Author(s):

Lihong Ma ◽

Zhengbo Song ◽

Yong Song ◽

Yiping Zhang

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective

Anti-Cancer Agents in Medicinal Chemistry ◽

10.2174/1871520615666150312100259 ◽

2015 ◽

Vol 15 (8) ◽

pp. 988-1011 ◽

Cited By ~ 3

Author(s):

Harun Patel ◽

Rajesh Rane ◽

Neeta Thapliyal ◽

Mahesh Palkar ◽

Mahamadhanif Shaikh ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Natural Origin ◽

Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma

JAMA Oncology ◽

10.1001/jamaoncol.2021.7015 ◽

2022 ◽

Author(s):

Oscar Arrieta ◽

Zyanya Lucia Zatarain-Barrón ◽

Jenny G. Turcott ◽

Feliciano Barrón ◽

Sai Yendamuri ◽

...

Keyword(s):

Receptor Tyrosine Kinase Inhibitors

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽